Clinical and Therapeutic Characteristics of Geriatric Patients Hospitalized for Heart Failure (AGING HF Study (AGe and Heart Failure IN Geriatrics))

NCT06377904 | Not Yet Recruiting DMC

• 1 other identifier: 2023-A02125-40
• Study Type: observational
• Target: 810
• Locations: 0 countries
• Sites: N/A

Brief Summary

This retrospective (between April 2020 and December 2023) then prospective (between January 2024 and August 2026), non-interventional cohort study has as its main objective to evaluate the clinical and therapeutic characteristics of patients aged 75 and over hospitalized in geriatrics for heart failure and also to evaluate the clinical characteristics and triggering factor(s) of acute heart failure.

Conditions

Patients Hospitalized in Geriatrics for Heart Failure; Patients Aged 75 and Over

Keywords

Heart failure; Geriatrics; AGE

Outcome Measures

Primary Outcomes (1)

• Evaluate the clinical and therapeutic characteristics of elderly patients hospitalized in geriatrics for heart failure

  To Evaluate the clinical and therapeutic characteristics of elderly patients hospitalized in geriatrics for heart failure with 80% power and 5% alpha risk and expressed as a percentage.

  36 months

Secondary Outcomes (1)

• Factors associated with patients hospitalization or rehospitalization

  12 months

Study Arms (2)

Retrospective phase

Retrospective inclusion (using data of patients who had been hospitalized between April 2020 and December 2023)

Prospective phase

Prospective inclusion (using data of patients hospitalized between January 2024 and August 2026)

Eligibility Criteria

• Age: 75 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients aged 75 and over hospitalized in geriatrics for heart failure

You may qualify if:

• Patients aged 75 and over Hospitalized in a geriatric ward with heart failure No oral opposition from patient

You may not qualify if:

• Patient under 75 years of age Patient not wishing to participate in the study Subject under guardianship/curatorship/supervision of justice

Sponsors & Collaborators

• Gérond'if: lead

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart Diseases; Cardiovascular Diseases

Central Study Contacts

Isabelle DUFOUR

CONTACT

+33 (01) 185 78 10 10; isabelle.dufour@gerondif.org

Prisca LUCAS, Project manager

CONTACT

+ 33 (01)85 78 10 10; prisca.lucas@gerondif.org

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: OTHER
• Target Duration: 1 Year
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 17, 2024
• First Posted: April 22, 2024
• Study Start: April 1, 2024
• Primary Completion (Estimated): April 1, 2027
• Study Completion (Estimated): April 1, 2028
• Last Updated: April 22, 2024

Record last verified: 2024-03